MedTrace Logo

Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

NCT01520753 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-01-04

No results posted yet for this study

Summary

This trial is conducted in Europe. The aim of this trial is to compare two different active treatment regimens of biphasic insulin aspart in subjects with type 2 diabetes.

Conditions

Interventions

DRUG

biphasic insulin aspart 70

Administered subcutaneously (s.c., under the skin) at breakfast, lunch and dinner

DRUG

biphasic insulin aspart 70

Administered subcutaneously (s.c., under the skin) at breakfast and lunch

DRUG

biphasic insulin aspart 50

Administered subcutaneously (s.c., under the skin) at dinner

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR,1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-03-31
Primary Completion
1999-06-30
Completion
1999-06-30

Countries

  • Denmark

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01520753 on ClinicalTrials.gov